A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19

por Ray, Yogiraj, Paul, Shekhar Ranjan, Bandopadhyay, Purbita, D’Rozario, Ranit, Sarif, Jafar, Raychaudhuri, Deblina, Bhowmik, Debaleena, Lahiri, Abhishake, Vasudevan, Janani Srinivasa, Maurya, Ranjeet, Kanakan, Akshay, Sharma, Sachin, Kumar, Manish, Singh, Praveen, Roy, Rammohan, Chaudhury, Kausik, Maiti, Rajsekhar, Bagchi, Saugata, Maiti, Ayan, Perwez, Md. Masoom, Mondal, Abhinandan, Tewari, Avinash, Mandal, Samik, Roy, Arpan, Saha, Moumita, Biswas, Durba, Maiti, Chikam, Bhaduri, Ritwik, Chakraborty, Sayantan, Sarkar, Biswanath Sharma, Haldar, Anima, Saha, Bibhuti, Sengupta, Shantanu, Pandey, Rajesh, Chatterjee, Shilpak, Bhattacharya, Prasun, Paul, Sandip, Ganguly, Dipyaman
Publicado 2022